AstraZeneca Oxford SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary paused
On Sept. 9, 2020, as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus…
US Government stopped COVID-19 entry strategy for international air passengers
On Sept. 9, 2020, the U.S, government annunced that it will remove requirements for directing all flights carrying…
Sinovac reported preliminary phase I/II results of COVID-19 vaccine in elderly volunteers
On Sept. 9, 2020, Sinovac Biotech announced that the inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences…
The ACIP updated flu vaccine recommendations for 2020-2021
On Sept. 9, 2020, the AAFP reviewed and agreed with the Advisory Committee on Immunization Practices’ recommendations for…
Valneva announced IXIAROï¾® supply contract with the US Government worth up to $166 million
On Sept. 9, 2020, Valneva announced the signing of a new contract, lasting up to three years, with…
Elevated levels of a blood clotting factor linked to worse outcomes in severe COVID-19
On Sept. 9, 2020, Harvard Medical School investigators at Massachusetts General Hospital reported that patients hospitalized with severe…
Head-to-head study demonstrated equivalency and accuracy of COVID-19 rapid point-of-care tests, despite test sensitivity claims
On Sept. 9, 2020, BD (Becton, Dickinson) announced the results of a new research study that demonstrated performance…
Pfizer and BioNTech announced data from preclinical studies of mRNA-based vaccine candidate against COVID-19
On Sept. 9, 2020, Pfizer and BioNTech announced preliminary preclinical data in mouse and non-human primate models from…
BioNTech and Pfizer announced data from preclinical studies of mRNA-based vaccine candidate against COVID-19
On Sept. 9, 2020, Pfizer and BioNTech announced preliminary preclinical data in mouse and non-human primate models from…
Biotechnology | COVID-19 | Infectious Disease | Life Science History | Medicine | Non-Profit Research | Stem Cell | Therapeutics
California’s Stem Cell Agency and the Chan Zuckerberg Initiative partnered to create COVID-19 database
On Sept. 8, 2020, a new collaboration between the California Institute for Regenerative Medicine (CIRM) and the Chan…
Vaxartï¾’s oral COVID-19 vaccine candidate induced potent systemic and mucosal immune responses in preclinical studies
On Sept. 8, 2020, Vaxart announced pre-publication of a manuscript titled ﾓPreclinical studies of a recombinant adenoviral mucosal…
LabCorp launched first combined test for Covid-19, flu and RSV in time for flu season
On Sept. 8, 2020, LabCorpï¾® announced the launch of the first testing method to simultaneously detect COVID-19, influenza…
Albert Einstein College of Medicine received $16 million NIH grant to study cellular process linked to Alzheimerï¾’s disease
On Sept. 8, 2020, researchers at Albert Einstein College of Medicine, led by Ana Maria Cuervo, M.D., Ph.D.,…
DiaSorin Molecular received FDA clearance for the Simplexaï¾™ flu A/B & RSV direct gen II assay Simplexaï¾™ Flu A/B & RSV Direct Gen II Assay
On Sept. 8, 2020, DiaSorin Molecular announced that it had received FDA Clearance for its Simplexaï¾™ Flu A/B…
BioNTech and Pfizer receive regulatory approval to commence global phase 2/3 trial for COVID-19 vaccine candidate
On Sept. 7, 2020, Pfizer and BioNTech announced that the German regulatory authority, the Paul-Ehrlich-Institut, had approved the…
Persistent immune memory of COVID-19 found in recovered patient T cells
On Sept. 4, 2020, the University of Oxford researchers have found that natural infection with COVID-19 produces a…
Roche received FDA Emergency Use Authorization for the cobas SARS-CoV-2 & influenza A/B test for use on cobas 6800/8800 systems
On Sept. 4, 2020, Roche announced that the cobasï¾® SARS-CoV-2 & Influenza A/B Test for use on the…
Persistent immune memory of COVID-19 found in recovered patient T cells
On Sept. 4, 2020, the University of Oxford researchers found that natural infection with COVID-19 produces a robust…
US Departments of HHS and DoD announced collaboration with McKesson for COVID-19 vaccine distribution
On Sept. 4, 2020, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD),…
CureVac expected to receive up to 252 million Euros from German Federal Ministry of Research for further COVID-19 vaccine development
On Sept. 4, 2020, CureVac announced that it had received notification from the German Federal Ministry of Education…
Johnson & Johnson announced COVID-19 investigational vaccine candidate prevents severe clinical disease in hamsters
On Sept. 3, 2020, as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus…
Sanofi and GSK initiated Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate
On Sept. 3, 2020, Sanofi and GSK announced the start of the Phase 1/2 clinical trial for their…
US Government exercised option to purchase additional RAPIVAB from BioCryst for delivery to Srategic National Stockpile
On Sept. 3, 2020, BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services (HHS) had…
BioMedomics’ Sickle SCANï¾® approved by Department of Health in Australia
On Sept. 3, 2020, BioMedomics announced that the Therapeutic Goods Administration, a branch of the Department of Health…
ADMA Biologics launched COVID-19 ImmunoRank Neutralization MICRO-ELISA for detection of SARS-CoV-2
On Sept. 3, 2020, ADMA Biologics announced the launch of COVID-19 ImmunoRank Neutralization MICRO-ELISA, a proprietary, fully-validated ELISA…
Custom face shields aimed to block droplets, tackled COVID-19 for football players
On Sept. 3, 2020, researchers from the Virginia Tech Helmet Lab announced the development of a football helmet…
NIH to boost national COVID-19 testing capacity
On Sept. 2, 2020, the NIH announced $129.3 million in scale-up and manufacturing support for a new set…
US Army uniquely poised to battle global pandemic
On Sept. 2, 2020, the U.S. Army Medical Materiel Development Activity reported it was working to develop a…
Broad Institute provided COVID-19 screening for students, faculty and staff at more than 100 colleges and universities
On Sept. 2, 2020, Broad Institute of MIT and Harvard announced it had partnered with 108 public and…
Janssen discontinued Pimodivir influenza development program
On Sept. 2, 2020, the Janssen Pharmaceutical Companies of Johnson & Johnson announced that it had made a…